Lixelle
Device
Grifols, S.A.
Total Payments
$24,824
Transactions
18
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $24,824 | 18 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $24,824 | 18 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An Open Label Phase 1 Study to Compare the Safety and Tolerability of the AKST1210 Column at Different Blood-Flow Rates in Patients With End-Stage Renal Disease Undergoing Hemodialysis | Grifols, S.A. | $24,824 | 0 |
Top Doctors Receiving Payments for Lixelle
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Northridge, CA | $24,824 | 18 |
Ad
Manufacturing Companies
- Grifols, S.A. $24,824
Product Information
- Type Device
- Total Payments $24,824
- Total Doctors 0
- Transactions 18
About Lixelle
Lixelle is a device associated with $24,824 in payments to 0 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Grifols, S.A..
Payment data is available from 2022 to 2022. In 2022, $24,824 was paid across 18 transactions to 0 doctors.
The most common payment nature for Lixelle is "Unspecified" ($24,824, 100.0% of total).
Lixelle is associated with 1 research study, including "An Open Label Phase 1 Study to Compare the Safety and Tolerability of the AKST1210 Column at Different Blood-Flow Rates in Patients With End-Stage Renal Disease Undergoing Hemodialysis" ($24,824).